Current Proteomics
Title:Meet Our Editorial Board Member
Volume: 13 Issue: 4
Author(s): Norelle Daly
Affiliation:
Export Options
About this article
Cite this article as:
Daly Norelle, Meet Our Editorial Board Member, Current Proteomics 2016; 13 (4) . https://dx.doi.org/10.2174/157016461304161230215817
DOI https://dx.doi.org/10.2174/157016461304161230215817 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
16
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting the Mannose Receptor with Mannosylated Subunit Vaccines
Current Medicinal Chemistry Five Common Functional Polymorphisms in microRNAs (rs2910164, rs2292832, rs11614913, rs3746444, rs895819) and the Susceptibility to Breast Cancer: Evidence from 8361 Cancer Cases and 8504 Controls
Current Pharmaceutical Design Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers
Current Medicinal Chemistry New Advances in the Pathogenesis and Progression of Barrett’s Esophagus
Current Molecular Medicine Meet Our Editorial Board Member
Anti-Cancer Agents in Medicinal Chemistry Pharmaceutical Inhibition of Neddylation as Promising Treatments for Various Cancers
Current Topics in Medicinal Chemistry Honokiol: A Novel Natural Agent for Cancer Prevention and Therapy
Current Molecular Medicine Studies on Synthesis of Novel Triazolalkyl Tagged Trifluoromethyl Substituted Pyrimidine Derivatives and their Evaluation for Cytotoxic Activity
Letters in Drug Design & Discovery Editorial [Hot Topic: Functional Complementation, Molecular Targeted Strategies, and Chemo/Immuno-Sensitization in Cancer Treatment: Hurdles and Solutions (Guest Editor: A.R. Jazirehi)]
Current Drug Delivery Molecular Dynamics and Structural Studies of the Ets Domain-DNA Complexes
Current Bioinformatics An Overview of Hepatitis C Vaccines
Recent Patents on Inflammation & Allergy Drug Discovery Utilities of Some Carbon Nucleophiles in Heterocyclic Synthesis
Current Organic Chemistry Inhibition of TGF-β Signaling in Tumor Cells by Small Molecule Src Family Kinase Inhibitors
Anti-Cancer Agents in Medicinal Chemistry The EGFR Pathway Regulates BCRP Expression in NSCLC Cells: Role of Erlotinib
Current Drug Targets Resveratrol Targets in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Taking Risk Prediction to the Next Level. Advances in Biomarker Research for Atherosclerosis
Current Pharmaceutical Design Nano-Carriers of Combination Tumor Physical Stimuli-Responsive Therapies
Current Drug Delivery Functional Genomics Down Under: RNAi Screening in the Victorian Centre for Functional Genomics
Combinatorial Chemistry & High Throughput Screening Voltage-Dependent Potassium Channels Kv1.3 and Kv1.5 in Human Cancer
Current Cancer Drug Targets Peptides and Small Molecules Targeting the Plasminogen Activation System: Towards Prophylactic Anti-Metastasis Drugs for Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery